Clinical Trial Update: Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing sacubitril/valsartan to lifestyle intervention in patients with hypertrophic cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Newcastle University | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED